RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI

儿科幽门螺杆菌的危险因素和胃病

基本信息

  • 批准号:
    2540775
  • 负责人:
  • 金额:
    $ 20.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-30 至 2002-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (taken from the application) Helicobacter pylori (Hp) is the major cause world-wide of chronic-active gastric primary duodenal ulcers, and is linked to gastric cancer. Most Hp infections are acquired in childhood; why some individuals develop symptomatic disease and others do not is unclear. Histopathological studies suggest that the degree and type of inflammatory infiltrate in gastroduodenal lesions are significantly different in Hp-infected children compared to adults. However, these differences remain unexplained. Studies of the host immune response following initial Hp infection in childhood and the relationship to Hp virulence factors (i.e., vacA) bolstered by the evaluation of host risk factors for infection are critical to understand the pathogenesis of Hp infection. Our preliminary studies of Hp infection in children developed accurate non-invasive methods for detection of infection and showed a unique gastric mucosal inflammatory response with increased numbers of macrophages. In vitro, we demonstrated the impotence of IL-8 and RANTES chemokines for leukocyte activation and recruitment. Furthermore, we demonstrated a difference in the T-cell responses of Hp-infected versus uninfected patients. Overall hypothesis: among Hp infected children, there are host factors (i.e., ethnicity) and environmental cofactors (i.e., water source) which result in symptomatic disease and children with symptoms will be infected by virulent Hp strains and have a more significant mucosal inflammatory response. Specific aims: 1) determine the host factors and environmental cofactors necessary for symptomatic Hp infection in children. Hp-infected symptomatic endoscopy cases at 4 centers will be compared to age, gender and region-matched Hp-infected asymptomatic controls. 2) characterize the bacterial properties (i.e., phenotype, genotype) associated with pediatric Hp infection. The phenotype and genotype prevalence of Hp isolates obtained from infected cases will be evaluated in comparison to gastroduodenal disease severity. 3) characterize the host inflammatory response of Hp-infected children. The histopathology in comparison to the chemokine and cellular response in the gastric mucosa of infected children will be determined. The proposed research provides a systematic examination of the association between Hp strains and host exposure characteristics and the severity of clinical disease in children. These studies are prerequisite for understanding the host-bacterial interaction in initial infection and evolution of gastroduodenal inflammation and overall pathogenesis of Hp.
描述(取自申请)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BENJAMIN David GOLD其他文献

BENJAMIN David GOLD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BENJAMIN David GOLD', 18)}}的其他基金

Role of Infectious Agents in Pediatric Crohn's Disease
传染源在小儿克罗恩病中的作用
  • 批准号:
    6824565
  • 财政年份:
    2004
  • 资助金额:
    $ 20.62万
  • 项目类别:
Role of Infectious Agents in Pediatric Crohn's Disease
传染源在小儿克罗恩病中的作用
  • 批准号:
    6931945
  • 财政年份:
    2004
  • 资助金额:
    $ 20.62万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    6177576
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    2906175
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    2796618
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    7067999
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    6778813
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:
RISK FACTORS AND GASTRIC DISEASE IN PEDIATRIC H PYLORI
儿科幽门螺杆菌的危险因素和胃病
  • 批准号:
    6381096
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    6943174
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:
Risk factors for gastric disease in pediatric H. pylori
儿童幽门螺杆菌胃病的危险因素
  • 批准号:
    7067023
  • 财政年份:
    1997
  • 资助金额:
    $ 20.62万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 20.62万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.62万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 20.62万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.62万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.62万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.62万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 20.62万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了